How to buy NLS Pharmaceutics Ltd stock (NLS Pharmaceutics Ltd)

NLS Pharmaceutics Ltd is a biotechnology business based in the US. NLS Pharmaceutics Ltd shares (NLSP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.82 – a decrease of 6.67% over the previous week.

Our top picks for where to buy NLS Pharmaceutics stock

Buy NLS Pharmaceutics Ltd stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

NLS Pharmaceutics Ltd stock price (NASDAQ: NLSP)

Use our graph to track the performance of NLSP stocks over time.

NLS Pharmaceutics Ltd shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$1.82
52-week range	$1.73 - $24.34
50-day moving average more info button	$3.35
200-day moving average more info button	$5.83
Wall St. target price	$6.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-6.74

Is it a good time to buy NLS Pharmaceutics Ltd stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NLS Pharmaceutics Ltd price performance over time

Historical closes compared with the close of $1.8936 from 2024-12-24

1 week (2024-12-20)	-2.89%
1 month (2024-11-27)	-42.09%
3 months (2024-09-27)	-63.58%
6 months (2024-06-28)	773.03%

1 year (2023-12-28)	274.30%
2 years (2022-12-28)	-96.27%
3 years (2021-12-28)	49.2
5 years (2019-12-24)	N/A

NLS Pharmaceutics Ltd financials

Gross profit TTM	$0
Return on assets TTM	-227.76%
Return on equity TTM	-862.92%
Profit margin	0%
Book value	$-9.40
Market Capitalization more info button	$4.5 million

TTM: trailing 12 months

NLS Pharmaceutics Ltd share dividends

We're not expecting NLS Pharmaceutics Ltd to pay a dividend over the next 12 months.

You may also wish to consider:

• Novartis AG ADR (NVS.US) (3.85% forward annual dividend yield)

Have NLS Pharmaceutics Ltd's shares ever split?

NLS Pharmaceutics Ltd's shares were split on a 1:40 basis on 26 September 2024 . So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NLS Pharmaceutics Ltd shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for NLS Pharmaceutics Ltd shares which in turn could have impacted NLS Pharmaceutics Ltd's share price.

NLS Pharmaceutics Ltd share price volatility

Over the last 12 months, NLS Pharmaceutics Ltd's shares have ranged in value from as little as $1.73 up to $24.336. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NLS Pharmaceutics Ltd's is -0.522. This would suggest that NLS Pharmaceutics Ltd's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, NLS Pharmaceutics Ltd has bucked the trend.

To put NLS Pharmaceutics Ltd's beta into context you can compare it against those of similar companies.

• Jazz Pharmaceuticals (JAZZ.US): 0.573
• Novartis AG ADR (NVS.US): 0.505
• Teva Pharma Industries Ltd ADR (TEVA.US): 0.868

NLS Pharmaceutics Ltd overview

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor treatment for the chronic fatigue associated with the symptoms of Long-COVID; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist for improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. It has licensing agreements with NeuroLife-Sciences SAS for use of mazindol for the treatment of ADHD; and Eurofarma Laboratorios S. A. for commercialization and distribution of Nolazol in Latin America.

Frequently asked questions

What percentage of NLS Pharmaceutics Ltd is owned by insiders or institutions?
Currently 40.849% of NLS Pharmaceutics Ltd shares are held by insiders and 19.404% by institutions. When does the fiscal year end for NLS Pharmaceutics Ltd?
NLS Pharmaceutics Ltd's fiscal year ends in December. Where is NLS Pharmaceutics Ltd based?
NLS Pharmaceutics Ltd's address is: The Circle 6, Zurich, Switzerland, 8058 What is NLS Pharmaceutics Ltd's ISIN number?
NLS Pharmaceutics Ltd's international securities identification number is: CH0523961370